Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report

doi:10.4251/wjgo.v15.i6.1096

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2573)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

WORD

HTML

1260

Figures (1-2)

232

Sum=1596

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

175

Download

651

Sum=826

Jun 15, 2023 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. Jun 15, 2023; 15(6): 1096-1104
Published online Jun 15, 2023. doi: 10.4251/wjgo.v15.i6.1096

Full Size Figure Download Figure

Figure 1 Enhanced computed tomography images prior to and after combined treatment. A: Enhanced computed tomography (CT) before any treatment showed a lesion in the gastric wall; B: Enhanced CT after combined treatment revealed that the lesion was apparently decreased in size.

Citation: Zhou ML, Xu RN, Tan C, Zhang Z, Wan JF. Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report. World J Gastrointest Oncol 2023; 15(6): 1096-1104
URL: https://www.wjgnet.com/1948-5204/full/v15/i6/1096.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i6.1096